T2 Biosystems Inc (TTOO)
2.79
+0.05
(+1.82%)
USD |
NASDAQ |
Apr 26, 12:36
T2 Biosystems Enterprise Value: 49.69M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 49.69M |
| April 24, 2024 | 49.86M |
| April 23, 2024 | 49.51M |
| April 22, 2024 | 53.38M |
| April 19, 2024 | 51.62M |
| April 18, 2024 | 51.89M |
| April 17, 2024 | 51.45M |
| April 16, 2024 | 52.24M |
| April 15, 2024 | 51.71M |
| April 12, 2024 | 53.20M |
| April 11, 2024 | 42.96M |
| April 10, 2024 | 42.52M |
| April 09, 2024 | 42.85M |
| April 08, 2024 | 41.14M |
| April 05, 2024 | 41.19M |
| April 04, 2024 | 41.36M |
| April 03, 2024 | 40.97M |
| April 02, 2024 | 41.91M |
| April 01, 2024 | 42.02M |
| March 28, 2024 | 42.13M |
| March 27, 2024 | 40.64M |
| March 26, 2024 | 39.70M |
| March 25, 2024 | 40.29M |
| March 22, 2024 | 39.75M |
| March 21, 2024 | 40.49M |
| Date | Value |
|---|---|
| March 20, 2024 | 40.94M |
| March 19, 2024 | 42.81M |
| March 18, 2024 | 44.98M |
| March 15, 2024 | 46.21M |
| March 14, 2024 | 45.42M |
| March 13, 2024 | 48.28M |
| March 12, 2024 | 48.43M |
| March 11, 2024 | 47.64M |
| March 08, 2024 | 49.81M |
| March 07, 2024 | 49.67M |
| March 06, 2024 | 49.42M |
| March 05, 2024 | 49.86M |
| March 04, 2024 | 51.64M |
| March 01, 2024 | 51.64M |
| February 29, 2024 | 46.05M |
| February 28, 2024 | 46.09M |
| February 27, 2024 | 47.10M |
| February 26, 2024 | 47.63M |
| February 23, 2024 | 47.59M |
| February 22, 2024 | 47.84M |
| February 21, 2024 | 48.12M |
| February 20, 2024 | 48.00M |
| February 16, 2024 | 47.71M |
| February 15, 2024 | 51.53M |
| February 14, 2024 | 50.88M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
30.93M
Minimum
Nov 30 2023
28.06B
Maximum
Feb 08 2021
4.321B
Average
3.244B
Median
Jul 29 2019
Enterprise Value Benchmarks
| Pacific Biosciences of California Inc | 631.09M |
| Sensus Healthcare Inc | 31.44M |
| Assure Holdings Corp | 18.81M |
| Shockwave Medical Inc | 12.04B |
| Autonomix Medical Inc | 62.88M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.34M |
| Revenue (Quarterly) | 1.679M |
| Total Expenses (Quarterly) | 11.00M |
| EPS Diluted (Quarterly) | -2.548 |
| Gross Profit Margin (Quarterly) | -53.31% |
| Profit Margin (Quarterly) | -615.8% |
| Earnings Yield | -5.23K% |
| Normalized Earnings Yield | -5025.68 |